GSK3 modulation in acute lung injury, myocarditis and polycystic kidney disease-related aneurysm
GSK3 modulation in acute lung injury, myocarditis and polycystic kidney disease-related aneurysm is a paper indexed in ScholarIQ from OpenAlex.
How many citations does GSK3 modulation in acute lung injury, myocarditis and polycystic kidney disease-related aneurysm have?
GSK3 modulation in acute lung injury, myocarditis and polycystic kidney disease-related aneurysm has 11 citations in the OpenAlex counts ScholarIQ stores.
When was GSK3 modulation in acute lung injury, myocarditis and polycystic kidney disease-related aneurysm published?
GSK3 modulation in acute lung injury, myocarditis and polycystic kidney disease-related aneurysm has 2020 year in the ScholarIQ index.
What is the open-access status of GSK3 modulation in acute lung injury, myocarditis and polycystic kidney disease-related aneurysm?
GSK3 modulation in acute lung injury, myocarditis and polycystic kidney disease-related aneurysm has bronze oa status in the ScholarIQ index.
What is the DOI of GSK3 modulation in acute lung injury, myocarditis and polycystic kidney disease-related aneurysm?
The DOI for GSK3 modulation in acute lung injury, myocarditis and polycystic kidney disease-related aneurysm is on the source record.
What is the PMID of GSK3 modulation in acute lung injury, myocarditis and polycystic kidney disease-related aneurysm?
The PMID for GSK3 modulation in acute lung injury, myocarditis and polycystic kidney disease-related aneurysm is on the source record.
What is the OpenAlex record for GSK3 modulation in acute lung injury, myocarditis and polycystic kidney disease-related aneurysm?
The OpenAlex for GSK3 modulation in acute lung injury, myocarditis and polycystic kidney disease-related aneurysm is on the source record.